{'Lilly': ['Lilly A 217'], 'Indianapolis': ['hemoglobin Indianapolis'], 'discover': ['Iscover'], 'pharmaceutical products': ['Pharmaceutical Preparations', 'Finished Pharmaceutical Product'], 'caring': ['Carine'], 'discovery': ['DISCOVERY -3'], 'medicines': ['Pharmaceutical Preparations', 'Analgesics'], 'products': ['Heme products (pharmacologic substance)', 'Product base', 'Gene Products, vif'], 'long-term': ['Memory, Long-Term'], 'Basaglar': ['Basaglar'], 'human': ['Humanin, human'], 'insulin analog': ['Insulin Analog [EPC]', 'Human insulin analog product', 'Insulin', 'insulin, regular, human'], 'Humalog Mix': ['Humalog Mix', 'humalog Mix 50', 'Humalog', 'HumaLOG Pen'], 'Humalog': ['Humalog', 'HumaLOG Pen', 'Humalog Mix', 'humalog Mix 50'], 'insulin lispro': ['insulin lispro', 'insulin lispro / insulin lispro protamine, human', 'Insulin lispro protamine- and insulin lispro-containing product', 'Insulin lispro and insulin lispro protamine only product', 'insulin lispro / insulin lispro protamine, human Pen Injector'], 'insulin lispro protamine': ['insulin lispro protamine, human', 'Insulin lispro protamine- and insulin lispro-containing product', 'insulin lispro / insulin lispro protamine, human', 'Insulin lispro and insulin lispro protamine only product', 'neutral protamine lispro insulin'], 'insulin': ['Insulin', 'insulin, regular, human', 'Therapeutic Insulin', 'Insulin [EPC]'], 'analogs': ['Purine analog', 'Androgens, Synthetic', 'hormone analog', 'Prostaglandins, Synthetic'], 'Humulin': ['Humulin insulin', 'Humulin S', 'Humulin', 'Humulin L', 'Humulin N'], 'Humulin N': ['Humulin N', 'Humulin insulin', 'Humulin S', 'Humulin'], 'Humulin R': ['Humulin R', 'Humulin insulin', 'Humulin S', 'Humulin', 'Humulin R Insulin'], 'insulins': ['Insulin', 'Insulins', 'insulin, regular, human', 'Therapeutic Insulin'], 'recombinant DNA origin': ['Recombinant DNA', 'Proteins, Recombinant DNA', 'somatropin', 'somatropin (recombinant DNA origin)'], 'Jardiance': ['Jardiance', 'Jardiance Pill'], 'cardiovascular death': ['Cardiovascular Agents'], 'adults': ['Adult Pain'], 'glucose-dependent insulinotropic polypeptide': ['Gastric Inhibitory Polypeptide', 'Gastric Inhibitory Polypeptide Receptor, human', 'Gastric Inhibitory Polypeptide, human', 'gastric inhibitory polypeptide receptor'], 'glucagon-like peptide-1 receptor agonist': ['GLP-1 Receptor Agonist [EPC]', 'Product containing glucagon-like peptide 1 receptor agonist (product)', 'Substance with glucagon-like peptide 2 receptor agonist mechanism of action (substance)'], 'combination': ['CAT combination'], 'Trulicit': ['Trulicity', 'Trulicity Pen'], 'pediatric': ['Pediatric brand name'], 'cardiovascular': ['Cardiovascular Agents'], 'agents': ['Renal Agents', 'Otic Agents', 'Otic Agents [TC]'], 'no epidermal growth factor receptor': ['Epidermal Growth Factor Receptor', 'EGFR protein, human', 'Epidermal growth factor receptor Ag'], 'anaplastic lymphoma kinase': ['anaplastic lymphoma kinase', 'ALK protein, human', 'Anaplastic lymphoma kinase Ag', 'Alk protein, rat'], 'agent': ['Pharmacologic Substance', '3-chloro-4,4-dimethyl-2-oxazolidinone'], 'Cyramza': ['Cyramza'], 'activating': ['Gain of Function Mutation', 'activation of actin binding'], 'epidermal growth factor receptor mutations': ['Epidermal Growth Factor Receptor', 'EGFR protein, human'], 'BTK inhibitor': ['BTK Inhibitor', "Bruton's Tyrosine Kinase Inhibitors [MoA]", 'BTK Inhibitor LOXO-305', 'CC-292', 'ACP-196'], 'Retevmo': ['Retevmo', 'Retevmo Pill', 'selpercatinib 40 MG Oral Capsule [Retevmo]', 'selpercatinib 80 MG Oral Capsule [Retevmo]'], 'transfection': ['Genetic transfection', 'Genetic Vectors', 'Transfectam', 'transfectACE'], 'RET mutation': ['Mutation'], 'Innovent Biologics': ['Biological Factors', 'Biopharmaceuticals'], 'Alimta': ['Alimta', 'pemetrexed 100 MG Injection [Alimta]'], 'endocrine therapy': ['ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS'], 'Olumiant': ['Olumiant', 'Olumiant Pill', 'Olumiant Oral Product'], 'supplemental oxygen': ['oxygen'], 'psoriasis': ['S100A7 protein, human', 'Psoriasin'], 'fibromyalgia': ['Fibromyalgia Agents'], 'Emgality': ['Emgality', 'Emgality Prefilled Pen'], 'Zyprexa': ['Zyprexa', 'Zyprexa Pill', 'Zyprexa Oral Product', 'ZyPREXA Zydis', 'olanzapine 10 MG Injection [Zyprexa]'], 'associated with': ['Probable E3 Ubiquitin-Protein Ligase MYCBP2'], 'Bamlanivimab': ['bamlanivimab', 'bamlanivimab Injection', 'bamlanivimab and etesevimab drug combination', 'bamlanivimab 35 MG/ML', 'Bamlanivimab only product'], 'etesevimab': ['etesevimab', 'etesevimab Injection', 'bamlanivimab and etesevimab drug combination', 'etesevimab 35 MG/ML', 'etesevimab Injectable Product'], 'SARS-CoV-2': ['Ribonucleic acid of Severe acute respiratory syndrome coronavirus 2 (substance)', 'nucleocapsid phosphoprotein, SARS-CoV-2', 'Severe acute respiratory syndrome coronavirus 2 DNA', 'Severe acute respiratory syndrome coronavirus 2 IgG'], 'progression': ['progressin'], 'bamlanivimab': ['bamlanivimab', 'bamlanivimab Injection', 'bamlanivimab and etesevimab drug combination', 'bamlanivimab 35 MG/ML', 'Bamlanivimab only product'], 'Bebtelovimab': ['bebtelovimab', 'bebtelovimab Injection', 'Bebtelovimab only product', 'bebtelovimab Injectable Product'], 'bebtelovimab': ['bebtelovimab', 'bebtelovimab Injection', 'Bebtelovimab only product', 'bebtelovimab Injectable Product'], 'men': ['Menogaril'], 'glucocorticoid-induced osteoporosis': ['Gig1 protein, mouse'], 'needs': ['human needs'], 'promote': ['Promoter'], 'samples': ['Specimen'], 'media channels': ['Ion Channel', 'narrow pore, gated channel activity', 'Calcium Release Activated Calcium Channels', 'water channel', 'Chloride Channels'], 'supplement': ['oral supplement'], 'arrangements': ['Gene Order', 'Gene Rearrangement'], 'channels': ['Ion Channel', 'narrow pore, gated channel activity', 'Calcium Release Activated Calcium Channels', 'water channel', 'Chloride Channels'], 'promotion arrangements': ['Gene Order', 'Gene Rearrangement'], 'pharmaceutical companies': ['Pharmaceutical Preparations'], 'Trajenta': ['Tradjenta'], 'Jentadueto': ['Jentadueto', 'Jentadueto XR', 'Jentadueto Pill', 'Jentadueto Oral Product'], 'Glyxambi &#174': ['Glyxambi'], 'XR': ['XR Bond'], 'Arrangements': ['Gene Order', 'Gene Rearrangement'], 'compete': ['Compete'], 'competitive': ['Binding, Competitive'], 'factors': ['Colicin Plasmids', 'F Factor', 'R Factors'], 'processes': ['Mental Processes'], 'biosimilar': ['Biosimilars', 'Biosimilar Drugs'], 'therapeutic': ['Therapeutic brand of coal tar', 'Therapeutic-M'], 'discovering': ['Iscover'], 'deliver value': ['DELIVER (veterinary product)', 'DELIVER (Dietary Supplement)'], 'uncompetitive': ['Binding, Competitive'], 'Generic': ['Generic Drugs'], 'Pharmaceuticals': ['Pharmaceutical Preparations', 'Pharmacologic Substance'], 'pharmaceuticals': ['Pharmaceutical Preparations', 'Pharmacologic Substance'], 'regulatory approval process': ['Regulation of biological process'], 'biological products': ['Biological Factors', 'Biological Products'], 'biologics': ['Biological Factors', 'Biopharmaceuticals'], 'generics': ['terics'], 'competition': ['Antigen competition'], 'product': ['product - ParticipationType', 'Oral Product', 'Proteins'], 'portion': ['Portia brand of ethinyl estradiol/levonorgestrel'], 'utilization': ['carbon utilization', 'acetate utilization'], 'cases': ['caspase'], 'drugs': ['Pharmaceutical Preparations'], 'generic': ['Generic Drugs'], 'regulates': ['Regulation of biological process'], 'Drug': ['Pharmaceutical Preparations', 'Pharmacologic Substance'], 'Cosmetic Act': ['cosmetin'], 'regulations': ['Regulation of biological process', 'Emotional Regulation'], 'Competition': ['Antigen competition'], 'follow-on': ['Biosimilar Pharmaceuticals'], 'biosimilars': ['Biosimilars'], 'version': ['versiol'], 'testing': ['Testin'], 'potency': ['Hi Potency Cal', 'drug potency'], 'regulatory pathways': ['Biochemical Pathway'], 'follow-ons': ['Biosimilar Pharmaceuticals'], 'Biologics': ['Biological Factors', 'Biopharmaceuticals'], 'Innovation': ['innovation reaction', 'Innovar', 'Innovativeness'], 'non-biologic products': ['Biological Products', 'Biological Factors'], 'biologic product': ['Biological Products', 'Biological Factors'], 'biosimilar products': ['Biosimilars'], 'insulin products': ['Insulin'], 'future': ['Feeling hopeless'], 'Biosimilars': ['Biosimilars'], 'challenges': ['Financial Stress'], 'consolidation': ['Memory Consolidation'], 'integration': ['DNA Integration', 'redintegration', 'Virus Integration'], 'consolidating': ['Memory Consolidation'], 'entities': ['Sense of identity (observable entity)'], 'control costs': ['CONTROL veterinary product'], 'exchange': ['Ion Exchange', 'exchanger'], 'reduced': ['2-mercaptoethanesulfonic acid'], 'usage': ['Codon Usage'], 'drug': ['Pharmaceutical Preparations', 'Pharmacologic Substance'], 'restrictions': ['tenascin R'], 'authorizations': ['special authorization'], 'factor': ['factor A', 'Factor V'], 'Affecting': ['Affection', 'Affect (mental function)'], 'Pharmaceutical Pricing': ['Pharmaceutical Preparations'], 'innovations': ['innovation reaction'], 'product uses': ['product - ParticipationType'], 'protection': ['CD59 Antigen', 'CD59 protein, human'], 'anticipated': ['anticipation'], 'compound patent': ['N-(2-(3,5-di-tert-butyl-4-hydroxyphenyl)-4-oxothiazolidin-3-yl-(4-chlorophenoxy))acetamide', '11-dehydrocorticosterone'], 'compounds': ['Corticosterone', 'Tin Compounds', 'Alum Compounds'], 'section': ['section sample'], 'PCT': ['Polychloroterphenyl Compounds'], 'relief': ['Relief brand of phenylephrine', 'Prelief', 'Ora Relief'], 'pharmaceutical product': ['Pharmaceutical Preparations', 'Finished Pharmaceutical Product'], 'formula': ['Formula B', 'Ato Formula'], 'duration': ['Duration brand of oxymetazoline', 'Duration'], 'Supplementary Protection': ['PROTEIN SUPPLEMENTS'], 'Australia': ['australine'], 'medicine': ['Pharmaceutical Preparations'], 'protections': ['Protectin', 'CD59 Antigen', 'CD59 protein, human'], 'recognition': ['Recognition, Psychology', 'precognition', 'Facial Recognition'], 'molecule': ['Molecule', 'RNA molecule', 'Molecular stability', 'DNA', 'caged molecule'], 'innovator': ['Innovar'], 'biologic': ['Biopharmaceuticals'], 'data': ['No Data re: Ingredient'], 'affecting': ['Affection', 'Affect (mental function)'], 'pharmaceutical inventions': ['Pharmaceutical Preparations'], 'biopharmaceutical products': ['Pharmaceutical Preparations', 'Biological Factors', 'Biopharmaceuticals', 'Finished Pharmaceutical Product', 'Radiopharmaceutical Medicinal Product'], 'molecules': ['Molecule', 'DNA', 'Small Molecule', 'Lyt molecules', 'RNA molecule'], 'Mounjaro': ['Mounjaro'], 'Taltz': ['Taltz'], 'Trulicity': ['Trulicity', 'Trulicity Pen'], 'Verzenio': ['Verzenio', 'Verzenio Pill', 'abemaciclib 50 MG Oral Tablet [Verzenio]', 'abemaciclib 100 MG Oral Tablet [Verzenio]'], 'Reyvow': ['Reyvow', 'Reyvow Pill'], 'Donanemab': ['Donanemab'], 'response': ['Response (communication)'], 'Lebrikizumab': ['lebrikizumab', 'mirikizumab'], 'Mirikizumab': ['mirikizumab', 'lebrikizumab'], 'product names': ['Namenda Oral Product'], 'continuing': ['Continuin', 'Chantix Continuing Month'], 'Drug Price': ['Pharmaceutical Preparations', 'Pharmacologic Substance'], 'innovative pharmaceuticals': ['Pharmaceutical Preparations', 'Pharmacologic Substance'], 'pharmaceutical equivalence': ['Pharmaceutical Preparations'], 'straightforward': ['Straightforward decision making'], 'NDA': ['NDA 150'], 'prohibited': ['prohibited', 'prohibitin', 'PHB protein, human'], 'trial': ['Triall'], 'judge': ['Judgment'], 'complex': ['NADH dehydrogenase (ubiquinone)', 'B-Complex'], 'IPR': ['inosine pranobex'], 'Generic drug': ['Generic Drugs', 'Pharmaceutical Preparations', 'Pharmacologic Substance'], 'process': ['Process Pharmacologic Substance'], 'pharmaceutical patents': ['Pharmaceutical Preparations'], 'Regulation': ['Regulation of biological process', 'Up-Regulation (Physiology)', 'Gene Expression Regulation'], 'cGMP': ['Cyclic GMP', '8-bromocyclic GMP', 'Cyclic GMP-Dependent Protein Kinases', 'cGMP binding', 'dipalmitoyl cyclic guanosinemonophosphate'], 'sale': ['salen'], 'regulation': ['Regulation of biological process', 'Up-Regulation (Physiology)', 'Gene Expression Regulation'], 'quality control': ['RNA surveillance'], 'labeling': ['psychosocial labeling'], 'promotion': ['Promotil'], 'surveillance': ['RNA surveillance'], 'connection': ['connectin', 'TTN protein, human'], 'export': ['Exportins'], 'storage': ['nitric oxide storage'], 'Pharmaceutical products': ['Pharmaceutical Preparations', 'Finished Pharmaceutical Product'], 'indications': ['Pharmaceutical Preparations'], 'EMA': ['human MUC1 protein'], 'National Medical Products': ['Pharmaceutical Preparations'], 'implement': ['Complement System Proteins'], 'comprehensive': ['Comprehension'], 'controls': ['mind control'], 'sustained': ['Sustain'], 'product recalls': ['Halls Oral Product'], 'interruption': ['interruptin B'], 'denials': ['Denial (Psychology)'], 'Human': ['Humanin, human'], 'medical products': ['Pharmaceutical Preparations'], 'manufactured': ['Manufactured gas'], 'actual': ['Ab actual'], 'regulatory processes': ['Regulation of biological process'], 'baricitinib': ['baricitinib', 'baricitinib 1 MG', 'baricitinib 2 MG', 'baricitinib 4 MG', 'baricitinib Pill'], 'regulators': ['Plant regulators'], 'antibodies': ['Antibodies', 'Blood group antibody i', "Sjogren's syndrome B antibody", 'a,b antibody'], 'practices': ['Practice Experience'], 'pharmaceutical industry': ['Pharmaceutical Preparations'], 'prohibits': ['prohibited', 'prohibitin', 'PHB protein, human'], 'traded': ['Tumor Necrosis Factor Receptor Superfamily Member 19'], 'intent': ['Intention - mental process'], 'improper advantage': ['Advantage brand of Imidacloprid', 'Advantage S'], 'FCPA': ['FCPA', 'FCPA potassium salt'], 'internal controls': ['internal control'], 'interaction': ['gene interaction'], 'interactions': ['Protein-Protein Interaction'], 'preventing': ['PREVENT (product)'], 'enhanced': ['Enhancer of transcription', 'Enhancer brand'], 'liquidity': ['Liquid substance'], 'pharmaceutical pricing': ['Pharmaceutical Preparations'], 'provision': ['urovision'], 'Inflation': ['lobeline'], 'thirteen': ['factor XIII', 'Factor XIIIa'], 'rate': ['Raticate'], 'inflation': ['lobeline'], 'influence': ['prenatal influences'], 'small molecule innovation': ['Small Molecule'], 'price setting': ['contextual factors'], 'program': ['Program'], 'drug products': ['Pharmaceutical Preparations'], 'Restrictive': ['tenascin R'], 'Monoclonal Antibodies': ['Monoclonal Antibodies', 'Antiviral monoclonal antibodies', 'Antibacterial monoclonal antibodies', 'Monoclonal antibodies, antineoplastic', 'Monoclonal Antibody [EPC]'], 'Amyloid': ['Amyloid', 'APP protein, human', 'Amyloid Proteins', 'Serum amyloid A protein'], 'monoclonal antibodies': ['Monoclonal Antibodies', 'Antiviral monoclonal antibodies', 'Antibacterial monoclonal antibodies', 'Monoclonal antibodies, antineoplastic', 'Monoclonal Antibody [EPC]'], 'target': ['Protein Targeting, Cellular'], 'amyloid': ['Amyloid', 'APP protein, human', 'Amyloid Proteins', 'Serum amyloid A protein'], 'donanemab': ['Donanemab'], 'annual': ['Gentianella amarella whole extract'], 'importers': ['porter activity'], 'prescription drugs': ['Prescription Drugs', 'Drugs, Non-Prescription'], 'gap': ['GTPase-Activating Proteins', 'Ras GTPase-Activating Protein 1, Human'], 'conduct': ['AXIN2 protein, human'], 'therapeutic reference': ['Therapeutic brand of coal tar'], 'pharmaceutical choices': ['Pharmaceutical Preparations'], 'German': ['Germanin'], 'Parliament passed': ['Parliament'], 'biopharmaceutical-focused': ['Biological Factors', 'Biopharmaceuticals'], 'responses': ['Response (communication)'], 'priorities': ['Personal priorities'], 'regulatory developments': ['regulation of bone development'], 'initiatives': ['Initiative', 'Cognitive function: initiation', 'Transcription Initiation'], 'commitment': ['commitment'], 'pharmaceutical research': ['Pharmaceutical Preparations'], 'therapeutic approaches': ['Therapeutic brand of coal tar'], 'complement': ['Complement System Proteins', 'Complement component C1', 'Complement 2', 'Complement 3', 'Complement component C5'], 'licensing arrangements': ['Gene Order', 'Gene Rearrangement'], 'acquisitions': ['Concept Acquisition'], 'Pharmaceutical development': ['Pharmaceutical Preparations'], 'Discovery': ['DISCOVERY -3'], 'biological': ['Biopharmaceuticals'], 'initiation': ['Cognitive function: initiation', 'Transcription Initiation'], 'animals': ['animal allergen extracts'], 'dosing': ['docusate'], 'Long-term': ['Memory, Long-Term'], 'phase varies': ['Phase Variation'], 'complete': ['Complete, Multiple Vitamins with Iron'], 'projects': ['Projection Defense Mechanism'], 'trials': ['Experimental drug'], 'complexity': ['Low Complexity Region', 'Cognitive Complexity'], 'decisions': ['Decision'], 'robust': ['robustic acid'], 'Raw Materials': ['Materials'], 'raw': ['Cereal plant straw'], 'materials': ['Materials'], 'lead': ['Plumbum metallicum, homeopathic preparation'], 'formulation': ['Formulation R'], 'assembling': ['assemblin', 'proteassemblin'], 'improve': ['Improvest'], 'pharmaceutical production processes': ['Pharmaceutical Preparations', 'Finished Pharmaceutical Product'], 'variability': ['variabilin', 'Antigenic Variation'], 'product sales': ['product - ParticipationType', 'Saleto Oral Product'], 'global': ['Globalin'], 'construction': ['Recombinant DNA'], 'confidence': ['Self Confidence', 'Confidence'], 'Product': ['product - ParticipationType', 'Oral Product', 'Proteins'], 'Business Experience': ['Practice Experience', 'Experience'], 'controller': ['Acid Controller'], 'Diversity': ['diversin'], 'API': ['alpha 1-antitrypsin', 'API 2'], 'Association': ['Mental association'], 'Apple': ['apple allergenic extract', 'apple extract'], 'positions': ['Gene Order'], 'biomedicines': ['Pharmaceutical Preparations'], 'attracting': ['ATRN protein, human', 'attractant'], 'strategy': ['Strategy'], 'nondiscrimination': ['Discrimination (process of differentiation)'], 'dedication': ['Pharmaceutical Preparations'], 'diversity': ['diversin'], 'experience': ['Practice Experience', 'Experience'], 'teams': ['Steam'], 'expectations': ['role expectation'], 'experiences': ['Experience', 'Practice Experience'], 'Asian': ['paramylon'], 'community initiatives': ['Initiative'], 'Foundation': ['Arthritis Foundation'], 'burden': ['Caregiver Burden'], 'increasing': ['cincreasin'], 'members': ['Mental Recall'], 'recognitions': ['Recognition, Psychology', 'Cognition', 'precognition'], 'Forbes': ['forbesione'], 'Dads': ['amsonic acid', "N,N'-bis(S-benzoylmercaptoacetyl)-2,3-diaminopropionic acid ethyl ester"], 'best': ['N,N-bis(2-hydroxyethyl)aminoethanesulfonic acid', 'Bestrophin-1'], 'talent': ['Talent', 'Transcription Activator-Like Effector Nucleases'], 'open positions': ['Gene Order'], 'Discover': ['Iscover'], 'learning': ['Learning', 'learning to learn', 'relearning'], 'connections': ['connectin', 'TTN protein, human'], 'learnings': ['Serial Learning', 'Visual learning', 'Verbal Learning'], 'promotes': ['Promoter'], 'growth experiences': ['Experience'], 'unique': ['Unique E'], 'advancement': ['Advance cement'], 'ideas': ['Abstract thinking ability'], 'awareness': ['Awareness', 'body awareness', 'Conscious', 'Spatial awareness'], 'live': ['liver extract'], 'Thrive': ['Thrive'], 'free of discrimination': ['Discrimination (process of differentiation)'], 'healthy': ['Healthy Colon'], 'well-being': ['mental health'], 'safeguard': ['Safeguard Antibacterial Foaming'], 'protect': ['CD59 Antigen', 'CD59 protein, human'], 'Annual': ['Gentianella amarella whole extract'], 'LILLY': ['Lilly A 217'], 'charters': ['Personality Character'], 'material': ['Materials', 'Red Material'], 'Data': ['No Data re: Ingredient'], 'cash': ['CASP8 and FADD-Like Apoptosis Regulator Protein', 'CFLAR protein, human'], 'materially': ['Materials'], 'Earnings': ['Serial Learning', 'Visual learning'], 'comparisons': ['Social Comparison'], 'inhibitor': ['Inhibitor', 'Androgen Receptor Inhibitor', 'c-Met Inhibitor', 'Angiotensin-Converting Enzyme Inhibitors'], 'GBA1': ['Gba protein, mouse', 'GBA protein, human'], 'Gene Therapy': ['Gene Therapy [APC]', 'Gene Therapy Agent'], 'estimated': ['estimation <subjective>'], 'transactions': ['Trans-Activation, Genetic'], 'Rigel Pharmaceuticals': ['Pharmaceutical Preparations', 'Pharmacologic Substance'], 'Rigel': ['cerigel'], 'Loxo': ['LOXO-101', 'BTK Inhibitor LOXO-305', 'potassium oxonate', 'RET Inhibitor LOXO-260', 'LOXO-195'], 'Qbrexza': ['Qbrexza', 'Qbrexza Medicated Pad or Tape', 'glycopyrronium 24 MG/ML Medicated Pad [Qbrexza]'], 'integration costs': ['DNA Integration'], 'Prevail': ['Prevail Injectable'], 'Compound': ['11-dehydrocorticosterone', 'fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether'], 'ANGPTL3': ['Angptl3 protein, mouse', 'ANGPTL3 protein, human', 'ANGPTL3 protein, zebrafish'], 'siRNA': ['RNA, Small Interfering', 'Small Interfering RNA [EPC]', 'siRNA binding', 'Trans-Acting siRNA', 'production of siRNA'], 'LP(a)': ['Lipoprotein (a)', 'Apolipoprotein(a), human', 'Apoprotein(a)'], 'Inhibitor': ['Inhibitor', 'Androgen Receptor Inhibitor', 'c-Met Inhibitor', 'Angiotensin-Converting Enzyme Inhibitors'], 'BTLA': ['B- and T-Lymphocyte Attenuator, Human', 'BTLA protein, mouse'], 'MAB': ['Monoclonal Antibodies', 'Monoclonal Antibody [EPC]', 'PA mAb', 'BAT monoclonal antibody', '7-iodo-8-hydroxy-3-methyl-1-(4-azidophenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine'], 'Agonist': ['Agonist', 'Mixed Agonist/Antagonist', 'STING Agonist', 'agonists'], 'CXCR1/2': ['CXCR1/2 Inhibitor RP72'], 'Ligands': ['ligands activity'], 'Monoclonal Antibody': ['Monoclonal Antibodies', 'Monoclonal Antibody [EPC]', 'monoclonal antibody CAL', 'BAT monoclonal antibody', 'Monoclonal Antibody B1'], 'Peresolimab': ['Peresolimab', 'spesolimab'], 'Rezpegaldesleukin': ['bempegaldesleukin'], 'Complete': ['Complete, Multiple Vitamins with Iron'], 'Response': ['Response (communication)'], 'Solanezumab': ['solanezumab', 'tanezumab', 'ponezumab', 'crenezumab', 'eptinezumab'], 'O-GlcNAcase': ['peptide O-linked N-acetylglucosamine-beta-N-acetylglucosaminidase', 'Protein O-GlcNAcase', 'OGA protein, human'], 'SSTR4': ['SSTR4 protein, human', 'somatostatin receptor 4', 'Sstr4 protein, rat', 'Sstr4 protein, mouse'], 'TRPA1': ['Transient Receptor Potential Cation Channel Subfamily A Member 1', 'Trpa1 protein, rat', 'TRPA1 Cation Channel', 'Trpa1 protein, mouse'], 'Selpercatinib': ['selpercatinib', 'selpercatinib Pill', 'selpercatinib 40 MG', 'selpercatinib 80 MG', 'selpercatinib Oral Product'], 'S.A.': ['nuelin'], 'pipeline': ['Pipeline contents'], 'NILEX': ['Senilex'], 'Empagliflozin': ['empagliflozin', 'empagliflozin 5 MG', 'empagliflozin 10 MG', 'empagliflozin Pill', 'empagliflozin 25 MG'], 'project': ['Projection Defense Mechanism', 'projectin'], 'estimate': ['estimation <subjective>', 'Stimate'], 'estimations': ['estimation <subjective>'], 'therapeutic category': ['Therapeutic Categories', 'Therapeutic brand of coal tar'], 'earnings': ['Serial Learning', 'Visual learning'], 'compound': ['11-dehydrocorticosterone', 'fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether'], 'Consolidation': ['Memory Consolidation'], 'restrictive': ['tenascin R'], 'excipients': ['Vaccine Excipients'], 'nitrosamines': ['Nitrosamines', 'nitrosamides', 'nitrosamide'], 'combinations': ['Short-acting sulfonamide combinations', 'Salt solution combinations', 'topical antibiotic combinations', 'lung surfactant combinations'], 'business combinations': ['Short-acting sulfonamide combinations', 'Salt solution combinations', 'topical antibiotic combinations', 'lung surfactant combinations'], 'strong': ['Strong acid'], 'limited': ['limited use'], 'quarter': ['Quarter Mate', 'Quartermaster'], 'incretin': ['Incretins', 'Product containing glucagon-like peptide 1 receptor agonist (product)', 'Gastric Inhibitory Polypeptide, human'], 'tax rate': ['Taxol'], 'enacting': ['enactin'], 'associations': ['Mental association'], 'Exchange': ['Ion Exchange', 'exchanger'], 'ended': ['MEND ashed powder'], 'Acquisitions': ['Concept Acquisition'], 'enhance': ['Enhancer of transcription', 'Enhancer brand'], 'financial strain': ['Financial Stress'], 'control': ['CONTROL veterinary product', 'Control brand of phenylpropanolamine'], 'region': ['Protein Domain'], 'components': ['Myeloma Proteins'], 'estimates': ['estimation <subjective>'], 'VBP': ['Topical VBP-926 Solution'], 'NM \n\nZyprexa &#174': ['Zyprexa'], 'compensatory actions': ['Compensation as a Defense Mechanism'], 'retention': ['Retention (Psychology)'], 'compensation costs': ['Compensation as a Defense Mechanism'], 'favorable': ['favor'], 'LIQUIDITY': ['Liquid substance'], 'cash flow': ['CASP8 and FADD-Like Apoptosis Regulator Protein'], 'short-term': ['Memory, Short-Term'], 'material cash': ['CASP8 and FADD-Like Apoptosis Regulator Protein'], 'Concord': ['CONCORD V', 'Concor', 'Concordin', 'Concord grape allergenic extract'], 'North Carolina': ['hemoglobin D Punjab'], 'Limerick': ['Limerick glass'], 'network': ['Gene Regulatory Networks'], 'Durham': ['spectrin Durham'], 'Cash': ['CASP8 and FADD-Like Apoptosis Regulator Protein', 'CFLAR protein, human'], 'CVR': ['FELOCELL CVR', 'FELOMUNE CVR'], 'paper program': ['Program'], 'balance': ['Balance (substance)'], 'derivatives': ['Amine and/or amine derivative', 'Caranes', 'Pinanes'], 'translating': ['Protein Biosynthesis', 'Genetic Translation Process'], 'exchange rates': ['Ion Exchange', 'exchanger'], 'sensitivity': ['Personality Sensitivity'], 'life cycle': ['Viral life cycle'], 'arrangement': ['Gene Order', 'DNA Sequence Rearrangement'], 'discretion': ['discretine'], 'moving': ['Movin B'], 'durations': ['Duration brand of oxymetazoline', 'Duration'], 'judgments': ['Judgment'], 'judgment': ['Judgment'], 'material adverse effect': ['light adverse effect'], 'transaction': ['Trans-Activation, Genetic'], 'revenue recognition': ['Recognition, Psychology'], 'denial': ['Denial (Psychology)'], 'revenue projections': ['Projection Defense Mechanism'], 'periodic': ['Periodic Acid'], 'pharmaceutical business': ['Pharmaceutical Preparations'], 'Estimates': ['estimation <subjective>'], 'projections': ['Projection Defense Mechanism', 'projectin'], 'Actual': ['Ab actual'], 'plan': ['Plan B'], 'ages': ['Glycation End Products, Advanced', 'Agestan'], 'taxing': ['taxine', 'TACC1 protein, human', 'taxinine', 'taxinine A', 'Ataxins'], 'position': ['Gene Order'], 'planning strategies': ['Strategy'], 'reversal': ['reversan']}
